Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2018-10-17 2018-10-17
Drug Identification Number 02310902 02310902
Brand name TEVA-ATORVASTATIN TEVA-ATORVASTATIN
Common or Proper name ATORVASTATIN ATORVASTATIN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ATORVASTATIN ATORVASTATIN
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 500
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-02-28 2018-02-28
Remaining supply date 2018-02-28 2018-02-28
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Transitioned. TEVA available Transitioned. TEVA available
Health Canada comments